The Fondaparinux Market size is expected to grow at an annual average of 6% during 2021-2027. Fondaparinux (Arixtra) is a synthetic anticoagulant based on the pentasaccharide sequence constituting the minimal antithrombin (AT) binding region of heparin. Similar to low molecular weight heparin, it is an indirect inhibitor of factor Xa, but not thrombin at all. Fondaparinux has a longer half-life than heparin and does not interact with platelets. Both can be advantageous in certain situations. The indications for fondaparinux include deep vein thrombosis, pulmonary embolism, and superficial vein thrombosis. Binding to antithrombin is the same sequence as UFH and LMWH, but it is not classified as a heparin agent because it lacks an extra chain. It is also known not to cause HIT, as seen in UFH and LMWH.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Fondaparinux Market at: https://www.orionmarketreports.com/request-sample/?id=78244
The following segmentation are covered in this report:
By Application
- Orthopedics (Hip or Knee Replacement)
- Cardiovascular
- Abdominal Surgery
- Others
By End User
- Clinics
- Hospitals
- Diagnostic centres
- Ambulatory Surgical Centres
- Home Care Settings
Company Profile
- Aurobindo Pharma Ltd
- Dr. Reddy’s Laboratories Ltd
- Mylan Inc.
- Jiangsu Hengrui Medicine Co. Ltd
- Scinopharm Taiwan Ltd
- Pfizer Inc
- Novartis AG
- Boehringer Ingelheim GmbH
- GlaxoSmithKline plc
The report covers the following objectives:
- Proliferation and maturation of trade in the global Fondaparinux Market
- The market share of the global Fondaparinux Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Fondaparinux Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Fondaparinux Market
Scope of the report
The research study analyses the Fondaparinux Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent developments
- Market overview and growth analysis
- Import and export overview
- Volume analysis
- Current market trends and future outlook
- Market opportunistic and attractive investment segment
A full report of Fondaparinux Market is available at: https://www.orionmarketreports.com/fondaparinux-market/78244/
Geographic coverage
- North america market size and/or volume
- Latin america market size and/or volume
- Europe market size and/or volume
- Asia-pacific market size and/or volume
- Rest of the world market size and/or volume
Key Questions Answered by Fondaparinux Market Report
- What was the Fondaparinux Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
- What will be the CAGR of Market during the forecast period (2021-2027)?
- Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
- Which manufacturer/vendor/players in the Fondaparinux Market was the market leader in 2020?
- Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
About us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company name: Orion Market Reports
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
